These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 9608109)
1. [The adviser on drugs in primary care]. Rodríguez Moreno C Aten Primaria; 1998 Mar; 21(5):261-3. PubMed ID: 9608109 [No Abstract] [Full Text] [Related]
2. [The advisor on drugs in primary care]. Baena L Aten Primaria; 1998 Nov; 22(9):608-9. PubMed ID: 9887586 [No Abstract] [Full Text] [Related]
3. [Analysis of the economic evaluation of drugs in primary care: concept, methodology and practical applications]. Soto Alvarez J; Fernández Cano P Aten Primaria; 1997 Dec; 20(10):563-8. PubMed ID: 9494217 [No Abstract] [Full Text] [Related]
4. [Study of imposed prescription in the basic areas of health of the Primary Health Care Administration in Sabadell]. Fidalgo García ML; González Martínez Y; Capataz Gallego M; López Bilbao C Aten Primaria; 1998 Sep; 22(4):261-2. PubMed ID: 9803580 [No Abstract] [Full Text] [Related]
5. [Are drugs worth their cost?]. Martín-Conde JA; Tévar Alfonso E; García García FJ Farm Hosp; 2011 May; 35 Suppl 2():32-9. PubMed ID: 22445507 [TBL] [Abstract][Full Text] [Related]
6. [Needs of cost-effectivity analysis for the optimization and rationalization of expense in new drugs]. Soto Alvarez J Med Clin (Barc); 2008 Apr; 130(14):559. PubMed ID: 18457627 [No Abstract] [Full Text] [Related]
7. Drugs in the Spanish health system. Laporte JR; Porta M; Capellà D; Arnau JM Int J Health Serv; 1984; 14(4):635-48. PubMed ID: 6437995 [TBL] [Abstract][Full Text] [Related]
9. Pharmacoeconomic series: Part I. Pharmacoeconomics and the evaluation of drugs and services. McGhan WF Hosp Formul; 1993 Apr; 28(4):365-6, 371-3, 377-8. PubMed ID: 10125323 [TBL] [Abstract][Full Text] [Related]
10. Cost-utility analysis of a pharmacotherapy follow-up for elderly nursing home residents in Spain. Jódar-Sánchez F; Martín JJ; López del Amo MP; García L; Araújo-Santos JM; Epstein D J Am Geriatr Soc; 2014 Jul; 62(7):1272-80. PubMed ID: 24891096 [TBL] [Abstract][Full Text] [Related]
11. Cost-cutting ideas: prescription drugs. Fish JL J Health Care Benefits; 1993; 3(1):10-3. PubMed ID: 10130342 [No Abstract] [Full Text] [Related]
12. [Economic-health care indicators in 2 health areas: the cost of the "consultation product" of primary health teams]. García Latorre FJ; Dolsac Espinosa JI; Cebrián Martín C; Lorente Valero F; Bastarós García JC Aten Primaria; 1994; 14(3):655-60. PubMed ID: 8086583 [TBL] [Abstract][Full Text] [Related]
13. Measuring the cost of drugs. Wittrick A Health Serv J; 1987 Jun; 97(5054):678. PubMed ID: 10312121 [No Abstract] [Full Text] [Related]
15. [Pharmacoeconomics: a new activity for the drug adviser in primary care?]. Soto Alvarez J Aten Primaria; 1999 Mar; 23(4):250, 252. PubMed ID: 10333612 [No Abstract] [Full Text] [Related]
16. Cost-effectiveness of therapeutic drug monitoring. Gardner DM; Hardy BG Can J Hosp Pharm; 1990 Feb; 43(1):7-12, xii. PubMed ID: 10113128 [TBL] [Abstract][Full Text] [Related]
17. [Health economic evaluation of recommended drug treatment]. Jendteg S; Persson U; Anell A Lakartidningen; 2002 Jul; 99(30-31):3130-1. PubMed ID: 12198934 [No Abstract] [Full Text] [Related]
18. A look at cost-effectiveness. Gibaldi M; Sullivan SD Pharmacotherapy; 1994; 14(4):399-414. PubMed ID: 7937277 [No Abstract] [Full Text] [Related]
19. Special report: the value of pharmaceuticals. An "expensive" drug may be the most cost effective. Siegelman S Bus Health; 1991; [VALUE]():8-14. PubMed ID: 10170908 [TBL] [Abstract][Full Text] [Related]